🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

resmetirom

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.

Tags: biopharmaceutical, cardiovascular, clinical-stage, liver diseases, metabolic, non-alcoholic steatohepatitis, resmetirom, therapeutic candidates

Website

About | Leadership | Directors | Contact | Contact | Contact | Careers | About | About

Symbol: MDGL

Recent Price: $311.62

Industry: Biotechnology

CEO: Mr. William J. Sibold

Sector: Healthcare

Employees: 376

Address: Four Tower Bridge, West Conshohocken, PA 19428

Phone: 267 824 2827

Leadership

  • BILL SIBOLD, Chief Executive Officer
  • REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
  • MARDI C. DIER, Chief Financial Officer
  • CAROLE HUNTSMAN, Chief Commercial Officer
  • CLINT WALLACE, Chief Human Resources Officer
  • RONALD FILIPPO, Chief Information Officer
  • STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
  • SHANNON KELLEY, General Counsel
  • MARK BARRETT, Chief Business Officer
  • MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
  • Julian C. Baker, Chairman and Director
  • Kenneth M. Bate, Director
  • Raymond Cheong, M.D., Ph.D., Director
  • Fred Craves, Ph.D., Director
  • James M. Daly, Director
  • Paul A. Friedman, M.D., Director
  • Richard S. Levy, M.D., Director
  • Bill Sibold, Director, Chief Executive Officer
  • Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development

Last updated: 2024-12-31